The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1642-1648

  Sulkowski, Mark S ^a   Chaisson, Richard E ^a   Karp, Christopher L ^a   Moore, Richard D ^a   Margolick, Joseph B ^a   Quinn, Thomas C ^a  

^a Richard Starr Ross Research Building ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; VIRUS DETECTION; VIRUS REPLICATION;

ACUTE DISEASE; ADULT; ANTIGENS, CD; CD4 LYMPHOCYTE COUNT; COMMUNICABLE DISEASES; CONVALESCENCE; CYTOKINES; HIV INFECTIONS; HUMANS; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 0031766130     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314491     Document Type: Article

References (18)

1. Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997;176:766-70.
2. Golletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol 1996;157:1271-8.
3. Bush CE, Donovan RM, Markowitz NP, et al. Changes in HIV RNA viral load in AIDS patients with Pneumocystis carinii pneumonia [abstract 654]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997.
4. Donovan RM, Bush CE, Markowitz NP, Baxan DM, Saravolatz LD. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis 1996;174:401-3.
5. Bush CE, Donovan RM, Markowitz NP, Kvale P, Saravolatz LD. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immune Defic Syndr 1996;13:23-6.
6. Schoenbaum EE, Farzadegan H, Gourevitch MN, et al. The effect of bacterial pneumonia on HIV viral load and T-cell phenotypes [abstract 259]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997.
7. Cooper ER, Damon B, Reinke D, et al. Clinical outcome and change in HIV-1 viral load following successful treatment of Mycobacterium avium complex (MAC) infection in children with HIV disease [abstract 698]. In: 4th Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997.
8. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997;276:1857-61.
9. Staprans SI, Hamilton BL, Follansbee SE, et al. Activation of virus replication after vaccination of HIV-infected individuals. J Exp Med 1995;182:1727-37.
10. O'Brien WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.
11. Ho DD. HIV-1 viremia and influenza. Lancet 1992;339:1549.
12. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1222-30.
13. Brichacek B, Swindells S, Janoff EN, Pirrucello S, Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis 1996;174:1191-9.
14. Chaisson RE, Gallant JE, Keruly JC, Moore RD. Impact of opportunistic diseases on survival in patients with HIV disease. AIDS 1998;12:29-33.
15. Whalen C, Horsburgh CR, Horn D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35.
16. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
17. Poli G, Kinter A, Justement JS, et al. Tumor necrosis factor-α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 1990;87:782-5.
18. Zangerle R, Gallati H, Sarcletti M, et al. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr 1994;7:79-85.